Search

Jonathan Yingling Phones & Addresses

  • Skillman, NJ
  • Livermore, CA
  • 13603 Alston Dr, Fishers, IN 46038 (317) 774-3655
  • 10679 Misty Hollow Ln, Fishers, IN 46038 (317) 915-1258
  • Nashville, TN
  • Chapel Hill, NC
  • Pewaukee, WI
  • Middleton, WI

Publications

Us Patents

Quinolinyl-Pyrrolopyrazoles

View page
US Patent:
7265225, Sep 4, 2007
Filed:
Nov 10, 2003
Appl. No.:
10/531237
Inventors:
Douglas Wade Beight - Frankfort IN, US
Jason Scott Sawyer - Indianapolis IN, US
Jonathan Michael Yingling - Fishers IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D 215/38
A61K 31/47
US Classification:
546157, 514314
Abstract:
A compound according to formula II and the pharmaceutically acceptable salts thereof and the method of treating cancer in a patient in need thereof by administration of said compound.

Pyrazolopyridine Derivatives As Pharmaceutical Agents

View page
US Patent:
7365066, Apr 29, 2008
Filed:
Sep 16, 2003
Appl. No.:
10/524577
Inventors:
Douglas Wade Beight - Frankfort IN, US
Rosanne Bonjouklian - Zionsville IN, US
Junkai Liao - Tewksbury MA, US
William Thomas McMillen - Indianapolis IN, US
Brandon Lee Parkhurst - Twin Rivers NJ, US
Jason Scott Sawyer - Indianapolis IN, US
Jonathan Michael Yingling - Fishers IN, US
Jeremy Schulenburg York - Indianapolis IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31/535
A61K 31/50
A01N 43/42
C07D 471/02
C07D 413/00
US Classification:
5142312, 5142345, 51425201, 514300, 546121, 544111, 544253
Abstract:
Novel pyrazolopyridine derivative compounds are disclosed and their use as pharmaceutical agents, in particular their use as TGF-beta signal transduction inhibitors useful in the treatment of cancer and other disease states influenced by TGF beta.

Quinolinyl-Pyrrolopyrazoles

View page
US Patent:
7834029, Nov 16, 2010
Filed:
Jul 25, 2007
Appl. No.:
11/782659
Inventors:
Douglas Wade Beight - Frankfort IN, US
Jason Scott Sawyer - Indianapolis IN, US
Jonathan Michael Yingling - Fishers IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31/04
C07D 215/38
US Classification:
514312, 546157, 546167
Abstract:
A compound according to formula II and the pharmaceutically acceptable salts thereof and the method of treating cancer in a patient in need thereof by administration of said compound.

Novel Pyrrole Derivatives As Pharmaceutical Agents

View page
US Patent:
20040106604, Jun 3, 2004
Filed:
Nov 6, 2003
Appl. No.:
10/477111
Inventors:
Douglas Beight - Frankfort IN, US
Todd DeCollo - Noblesville IN, US
Alexander Godfrey - Greenwood IN, US
Theodore Goodson - Indianapolis IN, US
Hong-Yu Li - Zionsville IN, US
William McMillen - Indianapolis IN, US
Shawn Miller - Noblesville IN, US
Jason Sawyer - Indianapolis IN, US
Edward Smith - Fishers IN, US
Jonathan Yingling - Fishers IN, US
International Classification:
A61K031/542
A61K031/538
A61K031/4745
C07D498/04
C07D491/04
US Classification:
514/224200, 514/230500, 514/303000, 544/048000, 544/105000, 546/119000
Abstract:
Novel pyrrazole derivative compounds and their use as pharmaceutical agents, in particular their use as TGF-beta signal transduction inhibitors. The disclosed invention relates to compounds of the structure (I) wherein (I) is a four, five, or six membered saturated ring and X is C, O or S.

Amazon

Breast Tumorigenesis: Interaction of Two Signaling Pathways -- TGR-Beta Versus Estrogen Receptor

View page
Author

Jonathan Yingling

Binding

Paperback

Publisher

PN

ISBN #

2

Jonathan M Yingling from Skillman, NJ, age ~55 Get Report